Diartis Pharmaceuticals Obtains New Financing
Feb 16, 2011 • Deals • TechZulu Inc.
| Company Name | Diartis Pharmaceuticals |
| Information Release Date | 2/16/2011 |
| Transaction Type | Venture Equity |
| Amount | Undisclosed |
| Round | Undisclosed |
| Proceeds Purpose | The company will focus on moving this exciting compound rapidly through early clinical development. Given the dramatic rise in the number of people with type 2 diabetes, there is a significant market need for a longer acting form of the GLP-1 analog exenatide. |
